Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-09 · accession 0001437749-23-000720 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-09 | 2022-12-30 | BKYI | LACOUS MIRA K | CTO | A - Grant | $0.5 | +2,500 | 19.1K | +15% | +$1,250 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | A | A | 2,500 | $0.5 | 19,125 | D | — | — | (F2) Holdings do not include options to purchase 15,626 shares. |